Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial
Nutrients · 26.04.2024 · 16 (9) · 1293
DOI: 10.3390/nu16091293 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 26.04.2024. Verfasst von Srikanta Pandit und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit, Department of Health & Family Welfare, Government of Bengal, J. B. Roy State Ayurvedic Medical College and Hospital, 170-172, Raja Din…. Hauptthemen laut MEDLINE: Withania, Plant Extracts, Stress, Psychological, Plant Leaves. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natreon (United States), Natreon Inc..
Abstract (Originalsprache)
Background
Stress is a known causative factor in modulating cognitive health, which overall well-being and quality of life are dependent on. Long-term stress has been shown to disrupt the balance of the hypothalamic–pituitary–adrenal (HPA) axis. Adaptogens, such as Withania somnifera (ashwagandha), are commonly used in Ayurvedic medicine for stress relief and ameliorating HPA-axis dysfunction. The aim of this study was to support the role of a root and leaf water-extracted ashwagandha extract (WS) in stress reduction by confirming the lowest clinically validated dose for stress management (125 mg/day) in a dose-dependent clinical study in adults with self-reported high stress.
Methods
An 8-week, randomized, double-blinded, placebo-controlled study to compare the effects of three different WS extract doses (125, 250 and 500 mg) was performed. A total of 131 adults were enrolled, and 98 were included in the final analysis. Attenuation of chronic stress was measured using the 14-item Perceived Stress Scale (PSS) and biochemical-related stress parameters.
Results
We have shown that aqueous WS extract (roots and leaves) safely reduces mild to moderate chronic stress at doses of 125 mg, 250 mg, and 500 mg/day for 8 weeks.
Conclusions
Our findings demonstrate the stress-reduction capabilities of this well-characterized aqueous extract of WS (root and leaf) at the low dose of 125 mg/day, in a dose-dependent manner, via the modulation of the HPA axis.
Trial registration
This study was registered with the Clinical Trials Registry—India (CTRI) with the registration number: CTRI/2019/11/022100.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Unit, Department of Health & Family Welfare, Government of Bengal, J. B. Roy State Ayurvedic Medical College and Hospital, 170-172, Raja Dinendra Street, Kolkata 700004, India.
- Section of Public and Population Health, School of Dentistry, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.
ORCID-Profile: Tapas K Sur, Yan Wang, Tuhin K Biswas
Förderung
- Natreon (United States)
- Natreon Inc.
Zitieren
APA
Pandit, S., Srivastav, A. K., Sur, T. K., Chaudhuri, S., Wang, Y., & Biswas, T. K. (2024). Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial. Nutrients, 16(9), 1293. https://doi.org/10.3390/nu16091293
Vancouver
Pandit S, Srivastav AK, Sur TK, Chaudhuri S, Wang Y, Biswas TK. Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial. Nutrients. 2024;16(9):1293. doi:10.3390/nu16091293
BibTeX
@article{Pandit2024,
author = {Pandit, Srikanta and Srivastav, Amit K and Sur, Tapas K and Chaudhuri, Supriyo and Wang, Yan and Biswas, Tuhin K},
title = {Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {9},
pages = {1293},
doi = {10.3390/nu16091293}
}
EUVIMED